This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes for military service members, veterans, and the broader population affected by rheumatoid arthritis. This work aligns with the program's broader objectives of advancing medical solutions for the battlefield and transforming healthcare through impactful research.
Generated 1/28/25, 10:36 AM